Granahan Investment Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-181,602
Closed -$7.1M 171
2022
Q3
$7.1M Buy
181,602
+75,331
+71% +$3.45M 0.23% 109
2022
Q2
$4.34M Buy
106,271
+7,660
+8% +$363K 0.15% 125
2022
Q1
$6.48M Sell
98,611
-15,676
-14% -$1.02M 0.16% 122
2021
Q4
$7.95M Sell
114,287
-4,588
-4% -$333K 0.16% 128
2021
Q3
$8.27M Sell
118,875
-23,657
-17% -$1.82M 0.16% 125
2021
Q2
$11.3M Buy
142,532
+9,710
+7% +$706K 0.21% 106
2021
Q1
$8.7M Sell
132,822
-32,285
-20% -$1.99M 0.18% 102
2020
Q4
$9.19M Buy
+165,107
New +$7.14M 0.21% 97
2020
Q3
Sell
-215,640
Closed -$9.69M 183
2020
Q2
$9.69M Buy
215,640
+1,034
+0.5% +$45K 0.35% 80
2020
Q1
$7.21M Buy
+214,606
New +$7.72M 0.39% 69
2016
Q1
Sell
-223,519
Closed -$5.02M 211
2015
Q4
$5.02M Sell
223,519
-312,488
-58% -$6.44M 0.17% 164
2015
Q3
$11.7M Sell
536,007
-1,087
-0.2% -$27.2K 0.36% 100
2015
Q2
$13.2M Buy
537,094
+11,990
+2% +$268K 0.37% 100
2015
Q1
$10.8M Buy
525,104
+157,768
+43% +$3.06M 0.31% 123
2014
Q4
$7.33M Sell
367,336
-10,719
-3% -$184K 0.21% 140
2014
Q3
$5.57M Buy
378,055
+239,440
+173% +$3.81M 0.17% 155
2014
Q2
$2.55M Buy
+138,615
New +$2.31M 0.07% 191

Other funds holding ATRC

Granahan Investment Management's ATRC Position: Q4 2022 in Review

Granahan Investment Management sold out of AtriCure (ATRC) in Q4 2022, closing a stake of 181,602 shares — an estimated $7.1M sold.

Granahan Investment Management first reported a position in ATRC in Q2 2014 and held it in 17 quarters. The position peaked at $13.2M in Q2 2015. 211 funds tracked by Wall St. Rank hold ATRC as of Q4 2022.

  • Granahan Investment Management reported no remaining AtriCure position as of Q4 2022 after selling out during the quarter.
  • Granahan Investment Management sold 181,602 AtriCure shares in Q4 2022, an estimated $7.1M.
  • Granahan Investment Management first reported a position in AtriCure in Q2 2014 and held it in 17 quarters.
  • Granahan Investment Management's AtriCure position peaked at $13.2M in Q2 2015.
  • 211 funds tracked by Wall St. Rank held AtriCure as of Q4 2022.

Based on Granahan Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.